4893 items matching your search terms.

Sodium-glucose cotransporter 2 inhibition: which patient with chronic kidney disease should be treated in the future?

Neuen, B. L. Jardine, M. J. Perkovic, V.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2020     DOI:10.1093/ndt/gfz252

Relative and absolute risk reductions in cardiovascular and kidney outcomes with canagliflozin across KDIGO risk categories: findings from the CANVAS program

Neuen, B. L. Ohkuma, T. Neal, B. Matthews, D. R. de Zeeuw, D. Mahaffey, K. W. Fulcher, G. Blais, J. Li, MBiostat Q. Jardine, M. J. Perkovic, V. Wheeler, D. C.
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020     DOI:10.1053/j.ajkd.2020.06.018

Strengthening screening for infectious diseases and vaccination among migrants in Europe: What is needed to close the implementation gaps?

Noori, T. Hargreaves, S. Greenaway, C. van der Werf, M. Driedger, M. Morton, R. L. Hui, C. Requena-Mendez, A. Agbata, E. Myran, D. T. Pareek, M. Campos-Matos, I. Nielsen, R. T. Semenza, J. Nellums, L. B. Pottie, K. Ecdc ad hoc scientific panel
TRAVEL MEDICINE AND INFECTIOUS DISEASE, 2020     DOI:10.1016/j.tmaid.2020.101715

Tamoxifen for hepatocellular carcinoma

Nowak, A. K. Findlay, M. Culjak, G. Stockler, M. R.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2020     DOI:10.1002/14651858.CD001024.pub3

Durvalumab with first-line chemotherapy in previously untreated malignant pleural mesothelioma (DREAM): a multicentre, single-arm, phase 2 trial with a safety run-in

Nowak, A. K. Lesterhuis, W. J. Kok, P. S. Brown, C. Hughes, B. G. Karikios, D. J. John, T. Kao, S. C. Leslie, C. Cook, A. M. Pavlakis, N. Briscoe, K. O'Byrne, K. J. Karapetis, C. S. Lam, W. S. Langford, A. Yip, S. Stockler, M. R.
LANCET ONCOLOGY, 2020     DOI:10.1016/S1470-2045(20)30462-9

Incidence of adverse events in minimally invasive versus open radical hysterectomy in early cervical cancer: results of a randomized controlled trial

Obermair, A. Asher, R. Pareja, R. Frumovitz, M. Lopez, A. Moretti-Marques, R. Rendon, G. Ribeiro, R. Tsunoda, A. Behan, V. Buda, A. Bernadini, M. Q. Zhao, H. Vieira, M. Walker, J. Spirtos, N. M. Yao, S. Chetty, N. Zhu, T. Isla, D. Tamura, M. Nicklin, J. Robledo, K. P. Gebski, V. Coleman, R. L. Salvo, G. Ramirez, P. T.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2020     DOI:10.1016/j.ajog.2019.09.036

Nurse-led advance care planning with older people who have end-stage kidney disease: feasibility of a deferred entry randomised controlled trial incorporating an economic evaluation and mixed methods process evaluation (ACReDiT)

O'Halloran, P. Noble, H. Norwood, K. Maxwell, P. Murtagh, F. Shields, J. Mullan, R. Matthews, M. Cardwell, C. Clarke, M. Morton, R. Shah, K. Forbes, T. Brazil, K.
BMC NEPHROLOGY, 2020     DOI:10.1186/s12882-020-02129-5

Kidney and cardiovascular protection with SGLT2 inhibitors: lessons from cardiovascular outcome trials and CREDENCE

O'Hara, D. V. Neuen, B. L. Jardine, M. J.
J NEPHROL, 2020     DOI:10.1007/s40620-020-00809-x

Identifying critically important cardiovascular outcomes for trials in hemodialysis: an international survey with patients, caregivers and health professionals

O'Lone, E. Howell, M. Viecelli, A. K. Craig, J. C. Tong, A. Sautenet, B. Herrington, W. G. Herzog, C. A. Jafar, T. H. Jardine, M. Krane, V. Levin, A. Malyszko, J. Rocco, M. V. Strippoli, G. Tonelli, M. Wang, A. Y. Wanner, C. Zannad, F. Winkelmayer, W. C. Wheeler, D. C.
NEPHROLOGY, DIALYSIS, TRANSPLANTATION, 2020     DOI:10.1093/ndt/gfaa008

Establishing core cardiovascular outcome measures for trials in hemodialysis: Report of an international consensus workshop

O'Lone, E. Viecelli, A. K. Craig, J. C. Tong, A. Sautenet, B. Herrington, W. G. Herzog, C. A. Jafar, T. H. Jardine, M. Krane, V. Levin, A. Malyszko, J. Rocco, M. V. Strippoli, G. Tonelli, M. Wang, A. Y. M. Wanner, C. Zannad, F. Winkelmayer, W. C. Wheeler, D. C. Song-Hd Cvd Consensus Workshop Investigators
AMERICAN JOURNAL OF KIDNEY DISEASES, 2020     DOI:10.1053/j.ajkd.2020.01.022

Relationships of adipocyte-fatty acid binding protein and lipocalin 2 with risk factors and chronic complications in type 2 diabetes and effects of fenofibrate: A fenofibrate Intervention and event lowering in diabetes sub-study

Ong, K. L. Wu, L. Januszewski, A. S. O'Connell, R. L. Xu, A. Rye, K. A. Ma, R. C. W. Li, H. Jenkins, A. J. Jia, W. Keech, A. C. Field study investigators
DIABETES RESEARCH AND CLINICAL PRACTICE, 2020     DOI:10.1016/j.diabres.2020.108450

Early change in albuminuria with canagliflozin predicts kidney and cardiovascular outcomes: A post hoc analysis from the CREDENCE trial

Oshima, M. Neuen, B. L. Li, J. Perkovic, V. Charytan, D. M. de Zeeuw, D. Edwards, R. Greene, T. Levin, A. Mahaffey, K. W. De Nicola, L. Pollock, C. Rosenthal, N. Wheeler, D. C. Jardine, M. J. Heerspink, H. J. L.
JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2020     DOI:10.1681/ASN.2020050723

Evidence from systematic reviews of randomized trials on enteral lactoferrin supplementation in preterm neonates

Pammi, M. Preidis, G. A. Tarnow-Mordi, W. O.
BIOCHEMISTRY AND CELL BIOLOGY, 2020     DOI:10.1139/bcb-2020-0136

Setting minimum clinical performance specifications for tests based on disease prevalence and minimum acceptable positive and negative predictive values: Practical considerations applied to COVID-19 testing

Ping Loh, T. Lord, S. J. Bell, K. Kathryn Bohn, M. Yee Lim, C. Markus, C. Fares Taie, H. Adeli, K. Lippi, G. Sandberg, S. Horvath, A.
CLINICAL BIOCHEMISTRY, 2020     DOI:10.1016/j.clinbiochem.2020.11.003

Validating the "feasibility, acceptability, cost, and equity" instrument using stakeholder perceptions of feasibility, acceptability, cost, and equity in guideline implementation

Pottie, K. Magwood, O. Rahman, P. Concannon, T. Alonso-Coello, P. Jaramillo Garcia, A. Santesso, N. Thombs, B. Welch, V. Wells, G. A. Saad, A. Archibald, D. Grad, R. Moore, A. Ximena Rojas, M. Iorio, A. Pinto, N. Doull, M. Morton, R. Santesso, N. Akl, E. A. Schunemann, H. J. Tugwell, P.
JOURNAL OF CLINICAL EPIDEMIOLOGY, 2020     DOI:10.1016/j.jclinepi.2020.11.018